A monoclonal-antibody drug reduced hospitalizations or death from Covid-19 by 85% compared with a placebo in a clinical trial, said Vir Biotechnology and GlaxoSmithKline, the drug’s developers.

Topline. Paxlovid—Pfizer’s antiviral Covid-19 treatment—is 37% effective at preventing hospitalization or death in high-risk patients compared with no treatment, according to a study ...

In response to the ongoing COVID-19 pandemic, a new study conducted by researchers at Yale and the University of British Columbia found that a lower-than-recommended dose of a common COVID-19 ...

A new drug being developed by Pfizer offers the possibility of nearly putting an end to deaths from COVID-19.. When given within five days of the onset of symptoms, the antiviral therapy, called ...

An experimental drug prevented half of severe coronavirus infections that would otherwise have sent COVID-19 patients to the hospital, a study shows. Hotspots ranked Start the day smarter ☀️ ...

Jan. 26, 2022 — The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab tests also ...

McMaster University researchers are leading a large international study to test drugs to treat COVID-19 patients. The trial will evaluate the effectiveness of ivermectin, metformin and fluvoxamine ...

Two Eli Lilly & Co. antibody-based drugs reduced Covid-19-related hospitalizations and deaths among recently diagnosed patients when given at lower doses than previously tested, a new study found ...

Researchers describe ensitrelvir as effective and generally well tolerated for COVID-19 prevention. Before the drug could become available in the United States, the Food and Drug Administration would ...

In a study published in the Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a small peptide was introduced nasally. The peptide proved effective in ...

Medicines designed to treat COVID-19 won't be available for months, so doctors are looking to drugs already approved for treating other diseases. Coronavirus drugs: Where we are and what we know ...

COVID-19 therapies made from a cocktail of two types of antibodies were effective against a wide range of variants of the coronavirus in a mice and hamster study, the Washington University School ...